Autor: "Ganesan, T. S." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.
Autorzy:: Rustin GJ; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex, UK. />Shreeves G
Nathan PD
Gaya A
Ganesan TS
Wang D
Boxall J
Poupard L
Chaplin DJ
Stratford MR
Balkissoon J
Zweifel M; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2010 Apr 27; Vol. 102 (9), pp. 1355-60. Date of Electronic Publication: 2010 Apr 13.
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carboplatin/*therapeutic use
Neoplasms/*drug therapy
Paclitaxel/*therapeutic use
Stilbenes/*therapeutic use
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/toxicity ; Ataxia/chemically induced ; Carboplatin/toxicity ; Carcinoma, Small Cell/drug therapy ; Carcinoma, Small Cell/pathology ; Dose-Response Relationship, Drug ; Esophageal Neoplasms/drug therapy ; Esophageal Neoplasms/pathology ; Female ; Humans ; Infusions, Intravenous ; Life Expectancy ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Male ; Melanoma/drug therapy ; Melanoma/pathology ; Middle Aged ; Neoplasms/pathology ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Paclitaxel/toxicity ; Patient Selection ; Stilbenes/administration & dosage ; Stilbenes/toxicity

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
Autorzy:: Jones PH; Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford OX3 7LJ, UK.
Christodoulos K
Dobbs N
Thavasu P
Balkwill F
Blann AD
Caine GJ
Kumar S
Kakkar AJ
Gompertz N
Talbot DC
Ganesan TS
Harris AL; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2004 Jul 05; Vol. 91 (1), pp. 30-6.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Angiogenesis Inhibitors/*pharmacology
Angiotensin-Converting Enzyme Inhibitors/*pharmacology
Captopril/*pharmacology
Dalteparin/*pharmacology
Enzyme Inhibitors/*pharmacology
Fibrinolytic Agents/*pharmacology
Hydroxamic Acids/*pharmacology
Neoplasms/*drug therapy
Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Biomarkers ; Captopril/administration & dosage ; Dalteparin/administration & dosage ; Drug Therapy, Combination ; Enzyme Inhibitors/administration & dosage ; Female ; Fibrinolytic Agents/administration & dosage ; Humans ; Hydroxamic Acids/administration & dosage ; Injections, Subcutaneous ; Lymphocytes/physiology ; Male ; Middle Aged ; Phytohemagglutinins/analysis ; Treatment Outcome ; Tumor Necrosis Factor-alpha/metabolism

Czasopismo naukowe

Skocz do pozycji: 3.

Tytuł:: Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents.
Autorzy:: Han C; Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford OX3 7LJ, UK.
Braybrooke JP
Deplanque G
Taylor M
Mackintosh D
Kaur K
Samouri K
Ganesan TS
Harris AL
Talbot DC; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2003 Oct 06; Vol. 89 (7), pp. 1166-71.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Clinical Trials, Phase I as Topic*
Antineoplastic Agents/*administration & dosage
Neoplasms/*drug therapy
Neoplasms/*mortality
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/metabolism ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/diagnosis ; Prognosis ; Retrospective Studies ; Risk Factors ; Survival Rate

Czasopismo naukowe

Skocz do pozycji: 4.

Tytuł:: A phase 1 study of tazarotene in adults with advanced cancer.
Autorzy:: Jones PH; MRC Cancer Cell Unit and Cancer Research UK Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge CB2 2XZ, UK. />Burnett RD
Fainaru I
Nadolny P
Walker P
Yu Z
Tang-Liu D
Ganesan TS
Talbot DC
Harris AL
Rustin GJ; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2003 Sep 01; Vol. 89 (5), pp. 808-15.
Typ publikacji:: Clinical Trial; Clinical Trial, Phase I; Journal Article
MeSH Terms:: Antineoplastic Agents/*pharmacokinetics
Antineoplastic Agents/*toxicity
Neoplasms/*drug therapy
Nicotinic Acids/*pharmacokinetics
Nicotinic Acids/*toxicity
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Area Under Curve ; Dose-Response Relationship, Drug ; Female ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Staging ; Nicotinic Acids/therapeutic use ; Retinoids/pharmacokinetics ; Retinoids/therapeutic use ; Retinoids/toxicity

Czasopismo naukowe

Informacja